Tobramycin ophthalmic Pregnancy and Breastfeeding Warnings
Tobramycin ophthalmic is also known as: AK-Tob, Tobralcon, Tobrasol, Tobrex, Tomycine
Overview
If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Tobramycin Drops while you are pregnant. It is not known if Tobramycin Drops are found in breast milk. Do not breast-feed while using Tobramycin Drops.
Tobramycin ophthalmic Pregnancy Warnings
Tobramycin ophthalmic has been assigned to pregnancy category B by the FDA. Animal reproductive studies revealed no evidence of impaired fertility or harm to the fetus at doses up to 33 times the human systemic dose. There are no controlled data in human pregnancy. Tobramycin ophthalmic should only be given during pregnancy when clearly needed.
Tobramycin ophthalmic Breastfeeding Warnings
There are no data on the excretion of tobramycin ophthalmic into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue the drug or to discontinue nursing, taking into account the importance of the drug to the mother.
See Also...
- Tobramycin use while Breastfeeding (in more detail)
- Tobramycin Drops Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
